144 related articles for article (PubMed ID: 11866308)
21. Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: a case report with autopsy examination.
Fukano M; Amano S; Sato J; Yamamoto K; Adachi H; Okabe H; Fujiyama Y; Bamba T
Hum Pathol; 2000 Feb; 31(2):250-3. PubMed ID: 10685643
[TBL] [Abstract][Full Text] [Related]
22. Rosiglitazone in the management of older patients with type 2 diabetes mellitus.
Kreider M; Heise M
Int J Clin Pract; 2002 Sep; 56(7):538-41. PubMed ID: 12296617
[TBL] [Abstract][Full Text] [Related]
23. Anticipated US approval for rosiglitazone and pioglitazone.
Diabetes Obes Metab; 1999 May; 1(3):181-2. PubMed ID: 11220298
[No Abstract] [Full Text] [Related]
24. Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group.
Murphy EJ; Davern TJ; Shakil AO; Shick L; Masharani U; Chow H; Freise C; Lee WM; Bass NM
Dig Dis Sci; 2000 Mar; 45(3):549-53. PubMed ID: 10749332
[TBL] [Abstract][Full Text] [Related]
25. [Pioglitazone].
Kobayashi M; Iwata M; Hiratani K
Nihon Rinsho; 2002 Sep; 60 Suppl 9():429-37. PubMed ID: 12387029
[No Abstract] [Full Text] [Related]
26. Serious liver injury. Leading reason for drug removals, restrictions.
Meadows M
FDA Consum; 2001; 35(3):8-9. PubMed ID: 11458559
[No Abstract] [Full Text] [Related]
27. Hepatocellular injury in a patient receiving pioglitazone.
Maeda K
Ann Intern Med; 2001 Aug; 135(4):306. PubMed ID: 11511159
[No Abstract] [Full Text] [Related]
28. [Thiazolidinediones in type 2 diabetes].
Baum U
Med Monatsschr Pharm; 2000 Jul; 23(7):210-3. PubMed ID: 10941251
[No Abstract] [Full Text] [Related]
29. Drug recalls underscore safety concerns.
Greene HL
Health News; 2000 May; 6(5):4. PubMed ID: 10851966
[No Abstract] [Full Text] [Related]
30. [Glitazones--a new class of drugs in treatment of type 2 diabetes].
Kleinwechter H
Dtsch Med Wochenschr; 2002 Feb; 127(8):400-1. PubMed ID: 11859452
[No Abstract] [Full Text] [Related]
31. Rosiglitazone--useful drug but has side effects.
Vidhya S; Mohan V
J Assoc Physicians India; 2002 Apr; 50():615. PubMed ID: 12164432
[No Abstract] [Full Text] [Related]
32. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.
Osei SY; Koro CE; Cobitz AR; Kolatkar NS; Stender M
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1244-6. PubMed ID: 19655316
[No Abstract] [Full Text] [Related]
33. Actos (pioglitazone).
TreatmentUpdate; 2001; 13(7):5-6. PubMed ID: 11794862
[No Abstract] [Full Text] [Related]
34. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al.
Beiderbeck AB; Sakaguchi M
Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1247-9. PubMed ID: 19842093
[No Abstract] [Full Text] [Related]
35. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study.
Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Mizoguchi S; Ibuki M; Tani T; Tanabe K; Nagai K; Shiratori K; Morioka S; Yoshikawa J
Am Heart J; 2003 Aug; 146(2):E5. PubMed ID: 12891212
[TBL] [Abstract][Full Text] [Related]
36. [New insulin sensitizers].
Einecke D
MMW Fortschr Med; 1999 Oct; 141(42):6. PubMed ID: 10912094
[No Abstract] [Full Text] [Related]
37. Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus.
Irons BK; Greene RS; Mazzolini TA; Edwards KL; Sleeper RB
Pharmacotherapy; 2006 Feb; 26(2):168-81. PubMed ID: 16466323
[TBL] [Abstract][Full Text] [Related]
38. Fatal liver failure associated with pioglitazone.
Farley-Hills E; Sivasankar R; Martin M
BMJ; 2004 Aug; 329(7463):429. PubMed ID: 15321899
[No Abstract] [Full Text] [Related]
39. Hepatic failure in a patient taking rosiglitazone.
Forman LM; Simmons DA; Diamond RH
Ann Intern Med; 2000 Jan; 132(2):118-21. PubMed ID: 10644272
[TBL] [Abstract][Full Text] [Related]
40. Effects of pioglitazone on diabetes-related outcomes in Hispanic patients.
Jun JK; Gong WC; Mathur R
Am J Health Syst Pharm; 2003 Mar; 60(5):469-73. PubMed ID: 12635453
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
